Intravenous fentanyl for cancer pain: A "fast titration" protocol for the emergency room

被引:27
作者
Soares, LGL [1 ]
Martins, M [1 ]
Uchoa, R [1 ]
机构
[1] Inst Nacl Canc, Ctr Suporte Terapeut Oncol, BR-22231100 Rio De Janeiro, Brazil
关键词
severe cancer pain; emergency room; intravenous fentanyl; titration;
D O I
10.1016/S0885-3924(03)00314-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Patients with cancer sometimes are admitted to the emergency room due to severe pain. Despite the fact that morphine's hydrophilicity can delay its peak effects after intravenous administration up to 30 minutes, it is still the most commonly used opioid during cancer pain emergencies. Fentanyl is a synthetic, lipophilic opioid, more potent than morphine, and achieves peak effects after intravenous administration in 5 minutes. According to our observations, intravenous fentanyl could be safety used in the emergency room to treat patients who need fast titration Of an opioid to control their pain. In our study, jentanyl was employed in a four-step, protocol to treat patients admitted to our palliative care emergency room due to severe pain, regardless of the previous use of morphine at home. Titration with intravenous fentanyl was successfully employed in 18/18 (100%) patients, with an average time for pain control at about 11 minutes, and without relevant adverse effects. We conclude that intravenous jentanyl could be safely used for severe cancer pain when rapid titration is being considered. (C) 2003 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:876 / 881
页数:6
相关论文
共 30 条
[11]  
Herz A., 1971, ADV DRUG RES, V6, P79
[12]   STEADY-STATE INFUSIONS OF OPIOIDS IN HUMAN VOLUNTEERS .1. PHARMACOKINETIC TAILORING [J].
HILL, HF ;
SAEGER, L ;
BJURSTROM, R ;
DONALDSON, G ;
CHAPMAN, CR ;
JACOBSON, R .
PAIN, 1990, 43 (01) :57-67
[13]   Intravenous morphine for emergency treatment of cancer pain [J].
Kumar, KS ;
Rajagopal, MR ;
Naseema, AM .
PALLIATIVE MEDICINE, 2000, 14 (03) :183-188
[14]  
Lawlor PG, 1998, CANCER, V82, P1167, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1167::AID-CNCR23>3.3.CO
[15]  
2-8
[16]   Subcutaneous fentanyl infusion in a patient with bowel obstruction and renal failure [J].
Mercadante, S ;
Caligara, R ;
Sapio, M ;
Serretta, R ;
Lodi, F .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 13 (04) :241-244
[17]   Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion [J].
Mercadante, S ;
Villari, P ;
Ferrera, P ;
Casuccio, A ;
Fulfaro, F .
CANCER, 2002, 95 (01) :203-208
[18]   Opioid poorly-responsive cancer pain. Part 2: Basic mechanisms that could shift dose response for analgesia [J].
Mercadante, S ;
Portenoy, RK .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2001, 21 (03) :255-264
[19]   Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain [J].
Moryl, N ;
Santiago-Palma, J ;
Kornick, C ;
Derby, S ;
Fischberg, D ;
Payne, R ;
Manfredi, PL .
PAIN, 2002, 96 (03) :325-328
[20]   Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain [J].
Payne, R ;
Coluzzi, P ;
Hart, L ;
Simmonds, M ;
Lyss, A ;
Rauck, R ;
Berris, R ;
Busch, MA ;
Nordbrook, E ;
Loseth, DB ;
Portenoy, RK .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2001, 22 (01) :575-583